135 related articles for article (PubMed ID: 6245673)
21. Pathology of viral hepatitis and its sequelae.
MacSween RN
Clin Gastroenterol; 1980 Jan; 9(1):23-45. PubMed ID: 6249527
[No Abstract] [Full Text] [Related]
22. Expression of protease-activated receptors and tissue factor in human liver.
Rullier A; Senant N; Kisiel W; Bioulac-Sage P; Balabaud C; Le Bail B; Rosenbaum J
Virchows Arch; 2006 Jan; 448(1):46-51. PubMed ID: 16193294
[TBL] [Abstract][Full Text] [Related]
23. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic significance of fibrosis markers in hepatocellular carcinoma among patients with IFN-based therapy].
Nakagawa M; Asahina Y
Nihon Rinsho; 2015 Dec; 73 Suppl 9():668-73. PubMed ID: 26846019
[No Abstract] [Full Text] [Related]
25. [Relationship between hepatocellular carcinoma, liver cirrhosis and hepatitis B: a pathological study].
Zhonghua Yi Xue Za Zhi; 1982 May; 62(5):257-61. PubMed ID: 6290005
[No Abstract] [Full Text] [Related]
26. Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma.
Rasi G; Serafino A; Bellis L; Lonardo MT; Andreola F; Zonfrillo M; Vennarecci G; Pierimarchi P; Sinibaldi Vallebona P; Ettorre GM; Santoro E; Puoti C
World J Gastroenterol; 2007 Oct; 13(37):4986-95. PubMed ID: 17854142
[TBL] [Abstract][Full Text] [Related]
27. [Expression and its clinicopathological features of tumor rejective antigen 1 in human tissues of hepatocellular carcinoma and liver cirrhosis].
Zhang H; Huang DF; Wei Q; Hua TY; Li F; Huang JF
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):661-5. PubMed ID: 20943076
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
Wang D; Zhang X; Lu Y; Wang X; Zhu L
Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
[TBL] [Abstract][Full Text] [Related]
30. [Hepatitis B antigen in liver cirrhosis and hepatocellular carcinoma].
Bartók I; Decastello A
Orv Hetil; 1975 Jun; 116(23):1323-6. PubMed ID: 165444
[No Abstract] [Full Text] [Related]
31. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of hepatocellular carcinoma by fine needle biopsy of portal vein thrombosis.
de Sio I; Castellano L; Calandra M; Falzarano IR; Zeppa P
Ital J Gastroenterol; 1992 Feb; 24(2):75-6. PubMed ID: 1374276
[TBL] [Abstract][Full Text] [Related]
33. [Morphological demonstration of hepatitis B virus surface antigen in liver cirrhosis, fibrosis and hepatocellular carcinoma (author's transl)].
Chlumská A; Kautzner J
Cas Lek Cesk; 1981 Jun; 120(23):689-92. PubMed ID: 6265089
[No Abstract] [Full Text] [Related]
34. Hepatocellular dysplasia: immunohistochemical and morphometrical evaluation.
Pollice L; Ricco R; Russo S; Maiorano E; Pagniello G; Delfino-Pesce V
Appl Pathol; 1988; 6(2):73-81. PubMed ID: 2455530
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India--an autopsy study.
Sundaram C; Reddy CR; Ramana GV; Benerjea S; Venkataratnam G; Kumari GS; Reddy BS; Bhaskaran CS
Indian J Pathol Microbiol; 1990 Oct; 33(4):334-8. PubMed ID: 1966741
[TBL] [Abstract][Full Text] [Related]
36. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
Seo JH; Park BC
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
[TBL] [Abstract][Full Text] [Related]
37. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells.
Peng B; Liu F; Han R; Luo G; Cathopoulis T; Lu K; Li X; Yang L; Liu GY; Cai JC; Shi SL
Int J Biochem Cell Biol; 2015 Sep; 66():45-58. PubMed ID: 26205150
[TBL] [Abstract][Full Text] [Related]
38. The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma.
Shen J; Huang CK; Yu H; Shen B; Zhang Y; Liang Y; Li Z; Feng X; Zhao J; Duan L; Cai X
J Cell Mol Med; 2017 May; 21(5):986-992. PubMed ID: 28224705
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of cell cycle and apoptotic proteins in human liver pathologies.
Mitselou A; Karapiperides D; Nesseris I; Vougiouklakis T; Agnantis NJ
Anticancer Res; 2010 Nov; 30(11):4493-501. PubMed ID: 21115898
[TBL] [Abstract][Full Text] [Related]
40. Systems biology analysis of hepatitis C virus infection reveals the role of copy number increases in regions of chromosome 1q in hepatocellular carcinoma metabolism.
Elsemman IE; Mardinoglu A; Shoaie S; Soliman TH; Nielsen J
Mol Biosyst; 2016 Apr; 12(5):1496-506. PubMed ID: 27040643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
